Effects of Edaravone on Amyloid-β Precursor Protein Processing in SY5Y-APP695 Cells

[1]  Y. Hasegawa,et al.  Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction. , 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  N. Belyaev,et al.  Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer’s disease? , 2012, Journal of neurochemistry.

[3]  K. Blankenbach.  Temporal Effects , 2012, Handbook of Visual Display Technology.

[4]  E. Lindström,et al.  BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells , 2011, Journal of Biomedical Science.

[5]  A. Simon,et al.  Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex , 2011, Journal of neuroscience research.

[6]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[7]  V. Papadopoulos,et al.  Alzheimer's disease: effects of β-amyloid on mitochondria. , 2011, Mitochondrion.

[8]  A. V. Santhanam,et al.  Endothelial Nitric Oxide Modulates Expression and Processing of Amyloid Precursor Protein , 2010, Circulation research.

[9]  M. Bullido,et al.  A free radical‐generating system regulates APP metabolism/processing , 2010, FEBS letters.

[10]  Tao Wang,et al.  Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model , 2010, Molecular Neurodegeneration.

[11]  D. Dickson,et al.  Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brain , 2010, Journal of neurochemistry.

[12]  Robin A. J. Smith,et al.  Animal and human studies with the mitochondria‐targeted antioxidant MitoQ , 2010, Annals of the New York Academy of Sciences.

[13]  S. Adachi,et al.  Edaravone directly reacts with singlet oxygen and protects cells from attack. , 2010, Life sciences.

[14]  K. Lee,et al.  Naturally occurring phytochemicals for the prevention of Alzheimer’s disease , 2010, Journal of neurochemistry.

[15]  P. Taupin.  A dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. , 2010, Central nervous system agents in medicinal chemistry.

[16]  M. Beal,et al.  Coenzyme Q10 effects in neurodegenerative disease , 2009, Neuropsychiatric disease and treatment.

[17]  H. Fukui,et al.  The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation , 2009, Journal of bioenergetics and biomembranes.

[18]  M. Beal,et al.  Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. , 2009, Free radical biology & medicine.

[19]  R. Takahashi.  Edaravone in ALS , 2009, Experimental Neurology.

[20]  M. Araie,et al.  Edaravone, a Free Radical Scavenger, Protects against Retinal Damage in Vitro and in Vivo , 2009, Journal of Pharmacology and Experimental Therapeutics.

[21]  M. Fujiki,et al.  Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus , 2009, Seizure.

[22]  Y. Xiong,et al.  Edaravone, a free radical scavenger, is effective on neuropathic pain in rats , 2009, Brain Research.

[23]  B. Xiao,et al.  Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats , 2007, Neurotoxicity Research.

[24]  E. Ling,et al.  Antioxidants and neuroprotection in the adult and developing central nervous system. , 2008, Current medicinal chemistry.

[25]  T. Montine,et al.  Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. , 2008, Free radical biology & medicine.

[26]  Takashi Morihara,et al.  Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.

[27]  S. Todo,et al.  The novel antioxidant edaravone: from bench to bedside. , 2008, Cardiovascular therapeutics.

[28]  J. Quinn,et al.  Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[29]  T. Toki,et al.  Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia , 2007, Neuroscience Research.

[30]  B. Hyman,et al.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.

[31]  S. Sharma,et al.  Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. , 2007, European journal of pharmacology.

[32]  N. Chauhan,et al.  Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice , 2007, Phytotherapy research : PTR.

[33]  J. Tauskela.  MitoQ--a mitochondria-targeted antioxidant. , 2007, IDrugs : the investigational drugs journal.

[34]  T. Montine,et al.  Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment , 2007, Neurobiology of Disease.

[35]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[36]  W. Klein,et al.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  S. Shimazaki,et al.  The therapeutic efficacy of edaravone in extensively burned rats. , 2006, Archives of surgery.

[38]  Huadong Zhou,et al.  Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives. , 2006, Drug discovery today.

[39]  B. Kriem,et al.  Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway , 2006, Neurobiology of Disease.

[40]  Y. Ikeda,et al.  Edaravone inhibits the disease activity in rheumatoid arthritis , 2006, Journal of clinical pharmacy and therapeutics.

[41]  Y. Namiki,et al.  Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. , 2006, CNS drug reviews.

[42]  B. Teter,et al.  Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro , 2006 .

[43]  S. Weggen,et al.  Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42 , 2006 .

[44]  S. Weggen,et al.  Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. , 2006, Journal of neurochemistry.

[45]  J. Sayre,et al.  Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. , 2006, Journal of Alzheimer's disease : JAD.

[46]  B. Teter,et al.  Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. , 2006, Journal of Neuroscience Research.

[47]  T. Kazui,et al.  Experimental study on the protective effects of edaravone against ischemic spinal cord injury. , 2005, The Journal of thoracic and cardiovascular surgery.

[48]  M. Mishina,et al.  Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. , 2005, Neurologia medico-chirurgica.

[49]  M. Yoshioka,et al.  Temporal effects of edaravone, a free radical scavenger, on transient ischemia-induced neuronal dysfunction in the rat hippocampus. , 2005, European journal of pharmacology.

[50]  H. Akamatsu,et al.  Effects of edaravone on human neutrophil function , 2005, Acta anaesthesiologica Scandinavica.

[51]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[52]  M. Beal,et al.  The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. , 2005, Molecular neurobiology.

[53]  Chang Yong Lee,et al.  Potent Inhibitory effect of flavonoids in Scutellaria baicalensis on amyloid beta protein-induced neurotoxicity. , 2004, Journal of agricultural and food chemistry.

[54]  I. Santana,et al.  Cytochrome c oxidase is decreased in Alzheimer’s disease platelets , 2004, Neurobiology of Aging.

[55]  Toshiaki Watanabe,et al.  Structure–activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone) , 2003, Redox report : communications in free radical research.

[56]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[57]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[58]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[60]  K. Houkin,et al.  Neuroprotective effect of the free radical scavenger MCI-186 in patients with cerebral infarction: clinical evaluation using magnetic resonance imaging and spectroscopy. , 1998, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[61]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Watanabe,et al.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. , 1994, The Journal of pharmacology and experimental therapeutics.

[63]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[64]  T. Watanabe,et al.  Effect of MCI-186 on brain edema in rats. , 1989, Stroke.

[65]  K. Abe,et al.  Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. , 1988, Stroke.

[66]  S. Sorbi,et al.  Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain , 1983, Annals of neurology.